Cargando…
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
Timely diagnosis is crucial to improve the long-term survival of bladder cancer (BC) patients. The discovery of new BC biomarkers based in urine analysis is very attractive because this biofluid is in direct contact with the inner bladder layer, in which most of the neoplasms develop, and is non-inv...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066175/ https://www.ncbi.nlm.nih.gov/pubmed/33810601 http://dx.doi.org/10.3390/metabo11040199 |
_version_ | 1783682513183440896 |
---|---|
author | Pinto, Joana Carapito, Ângela Amaro, Filipa Lima, Ana Rita Carvalho-Maia, Carina Martins, Maria Conceição Jerónimo, Carmen Henrique, Rui Bastos, Maria de Lourdes Guedes de Pinho, Paula |
author_facet | Pinto, Joana Carapito, Ângela Amaro, Filipa Lima, Ana Rita Carvalho-Maia, Carina Martins, Maria Conceição Jerónimo, Carmen Henrique, Rui Bastos, Maria de Lourdes Guedes de Pinho, Paula |
author_sort | Pinto, Joana |
collection | PubMed |
description | Timely diagnosis is crucial to improve the long-term survival of bladder cancer (BC) patients. The discovery of new BC biomarkers based in urine analysis is very attractive because this biofluid is in direct contact with the inner bladder layer, in which most of the neoplasms develop, and is non-invasively collected. Hence, this work aimed to unveil alterations in the urinary volatile profile of patients diagnosed with BC compared with cancer-free individuals, as well as differences among patients diagnosed at different tumor stages, to identify candidate biomarkers for non-invasive BC diagnosis and staging. Urine analysis was performed by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). The results unveiled that BC patients have a distinct urinary volatile profile characterized by higher levels of several alkanes and aromatic compounds, and lower levels of aldehydes, ketones and monoterpenes. Seventeen significantly altered volatiles were used to evaluate the performance for overall BC detection, disclosing 70% sensitivity, 89% specificity and 80% accuracy. Moreover, distinct urinary volatile profiles were found among patients diagnosed at different tumor stages (Ta/Tis, T1 and ≥T2). This work identified distinct urinary volatile signatures of BC patients with potential for non-invasive detection and staging of bladder cancer. |
format | Online Article Text |
id | pubmed-8066175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80661752021-04-25 Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics Pinto, Joana Carapito, Ângela Amaro, Filipa Lima, Ana Rita Carvalho-Maia, Carina Martins, Maria Conceição Jerónimo, Carmen Henrique, Rui Bastos, Maria de Lourdes Guedes de Pinho, Paula Metabolites Article Timely diagnosis is crucial to improve the long-term survival of bladder cancer (BC) patients. The discovery of new BC biomarkers based in urine analysis is very attractive because this biofluid is in direct contact with the inner bladder layer, in which most of the neoplasms develop, and is non-invasively collected. Hence, this work aimed to unveil alterations in the urinary volatile profile of patients diagnosed with BC compared with cancer-free individuals, as well as differences among patients diagnosed at different tumor stages, to identify candidate biomarkers for non-invasive BC diagnosis and staging. Urine analysis was performed by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). The results unveiled that BC patients have a distinct urinary volatile profile characterized by higher levels of several alkanes and aromatic compounds, and lower levels of aldehydes, ketones and monoterpenes. Seventeen significantly altered volatiles were used to evaluate the performance for overall BC detection, disclosing 70% sensitivity, 89% specificity and 80% accuracy. Moreover, distinct urinary volatile profiles were found among patients diagnosed at different tumor stages (Ta/Tis, T1 and ≥T2). This work identified distinct urinary volatile signatures of BC patients with potential for non-invasive detection and staging of bladder cancer. MDPI 2021-03-26 /pmc/articles/PMC8066175/ /pubmed/33810601 http://dx.doi.org/10.3390/metabo11040199 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Pinto, Joana Carapito, Ângela Amaro, Filipa Lima, Ana Rita Carvalho-Maia, Carina Martins, Maria Conceição Jerónimo, Carmen Henrique, Rui Bastos, Maria de Lourdes Guedes de Pinho, Paula Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title | Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title_full | Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title_fullStr | Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title_full_unstemmed | Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title_short | Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics |
title_sort | discovery of volatile biomarkers for bladder cancer detection and staging through urine metabolomics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066175/ https://www.ncbi.nlm.nih.gov/pubmed/33810601 http://dx.doi.org/10.3390/metabo11040199 |
work_keys_str_mv | AT pintojoana discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT carapitoangela discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT amarofilipa discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT limaanarita discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT carvalhomaiacarina discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT martinsmariaconceicao discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT jeronimocarmen discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT henriquerui discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT bastosmariadelourdes discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics AT guedesdepinhopaula discoveryofvolatilebiomarkersforbladdercancerdetectionandstagingthroughurinemetabolomics |